| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |